Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 17, 2007 |
SVP, Research & Devel Sciences
Trans History: 683
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 95,438 | -- | 95,438 |
Dec 17, 2007 |
SVP, Commercial
Trans History: 172
|
SVP, Commercial | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 50,000 |
Dec 17, 2007 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
Dec 17, 2007 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 307,938 | -- | 307,938 |
Dec 17, 2007 |
VP & Gn Mgr Ind Ops & Prod Sup
Trans History: 365
|
VP & Gn Mgr Ind Ops & Prod Sup | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | -- | 40,000 |
Dec 17, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 500,000 | -- | 563,094 |
Dec 17, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
Dec 17, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 195,438 | -- | 195,438 |
Dec 12, 2007 |
Director
Trans History: 312
|
Director | Form 4 | Bona fide gift | 1,000 | -- | 5,975 |
Dec 12, 2007 |
Director
Trans History: 312
|
Director | Form 4 | Bona fide gift | 1,000 | -- | 4,975 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.